Studies have shown that the autophagy markers Beclin-1 and LC3 are significantly increased in patients with non-PCOS endometrial cancer, and that elevations in their levels correlate positively with tumor grade and myometrial invasion, and negatively with 5-year survival rate [205]. This evidence concerns the gene BECN1 and polycystic ovary syndrome.